🔬 A recent randomized clinical trial suggests a significant improvement in behavioral symptoms among children with moderate-to-severe Autism Spectrum Disorder (ASD) using low-THC full-spectrum cannabis extract. However, it’s crucial to acknowledge the complexity of this finding, as confounders such as individual response variability, concurrent medication use, and long-term effects remain to be fully explored. In clinical practice, healthcare providers may consider discussing the potential benefits and risks associated with cannabis therapy in managing symptoms of ASD, while emphasizing the need for ongoing monitoring and adjustment of treatment plans based on individual patient responses.